Filtros de búsqueda

Lista de obras de Gabriele Stefanzl

A kinase profile-adapted drug combination elicits synergistic cooperative effects on leukemic cells carrying BCR-ABL1T315I in Ph+ CML

scientific article published on 28 December 2018

BTK inhibition is a potent approach to block IgE-mediated histamine release in human basophils

artículo científico publicado en 2017

CD44 is a RAS/STAT5-regulated invasion receptor that triggers disease expansion in advanced mastocytosis

artículo científico publicado en 2018

Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia

artículo científico publicado en 2014

Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells.

artículo científico publicado en 2017

Effects of ibrutinib on proliferation and histamine release in canine neoplastic mast cells

scientific article published on 13 August 2019

Evaluation of cooperative antileukemic effects of nilotinib and vildagliptin in Ph+ chronic myeloid leukemia

artículo científico publicado en 2017

Evaluation of in vitro effects of various targeted drugs on plasma cells and putative neoplastic stem cells in patients with multiple myeloma.

artículo científico publicado en 2016

Identification of CD25 as STAT5-Dependent Growth Regulator of Leukemic Stem Cells in Ph+ CML.

artículo científico publicado en 2015

Identification of Ponatinib as a potent inhibitor of growth, migration, and activation of neoplastic eosinophils carrying FIP1L1-PDGFRA

artículo científico publicado en 2014

Identification of heat shock protein 32 (Hsp32) as a novel target in acute lymphoblastic leukemia

artículo científico publicado en 2014

Identification of the Ki-1 antigen (CD30) as a novel therapeutic target in systemic mastocytosis.

artículo científico publicado en 2015

In vitro effects of histamine receptor 1 antagonists on proliferation and histamine release in canine neoplastic mast cells

artículo científico publicado en 2020

Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia

artículo científico publicado en 2015

Maintenance therapy with histamine plus IL-2 induces a striking expansion of two CD56bright NK cell subpopulations in patients with acute myeloid leukemia and supports their activation

artículo científico publicado en 2016

Phenotyping and Target Expression Profiling of CD34+/CD38- and CD34+/CD38+ Stem- and Progenitor cells in Acute Lymphoblastic Leukemia.

artículo científico publicado en 2018

Target interaction profiling of midostaurin and its metabolites in neoplastic mast cells predicts distinct effects on activation and growth

artículo científico publicado en 2016

The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis.

artículo científico publicado en 2018

The pan-BCL-2-blocker obatoclax (GX15-070) and the PI3-kinase/mTOR-inhibitor BEZ235 produce cooperative growth-inhibitory effects in ALL cells.

artículo científico publicado en 2017

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda